SUMCO Metabolic Syndrome Project

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Yuichiro Nishida, Fukuoka University
ClinicalTrials.gov Identifier:
NCT01278628
First received: January 18, 2011
Last updated: August 8, 2016
Last verified: August 2016
  Purpose
Physical activity is considered important in prevention and treatment of obesity and metabolic syndrome. Genotype of genes involved in metabolism is also known to be associated with the development of metabolic syndrome. However, scarce evidence exists regarding the influence of physical activity intensity and genotype on metabolic syndrome in people with obesity. The investigators examine physical activity using an uniaxial accelerometer, as well as aerobic fitness using an electric bicycle ergometer, several genotypes of genes related to glucose and lipid metabolisms in middle-aged men with obesity and/or abdominal obesity who were employees in silicon wafer manufacture and participated in a health checkup.

Condition Intervention Phase
Metabolic Syndrome
Other: exercise training
Phase 1

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Health Services Research

Resource links provided by NLM:


Further study details as provided by Fukuoka University:

Primary Outcome Measures:
  • Components of metabolic syndrome [ Time Frame: every year ] [ Designated as safety issue: No ]

Enrollment: 114
Study Start Date: August 2009
Study Completion Date: December 2011
Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Lifestyle modification Other: exercise training
exercise class once a year

  Eligibility

Ages Eligible for Study:   40 Years to 74 Years   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • healthy people and individuals with obesity and metabolic syndrome

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01278628

Locations
Japan
SUMCO corporation
Imari, Saga, Japan, 849-4271
Sponsors and Collaborators
Fukuoka University
  More Information

Responsible Party: Yuichiro Nishida, Lecturer, Fukuoka University
ClinicalTrials.gov Identifier: NCT01278628     History of Changes
Other Study ID Numbers: 19200049sagasumco 
Study First Received: January 18, 2011
Last Updated: August 8, 2016
Health Authority: Japan: Ministry of Education, Culture, Sports, Science and Technology

Additional relevant MeSH terms:
Syndrome
Metabolic Syndrome X
Disease
Pathologic Processes
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on August 29, 2016